Scientia Press

Biophotonic Therapy uses light in an extracorporeal or intravenous mode to activate the red blood cells, a form of immunity inherited from humankind’s distant oligocellular ancestors. BT has an instructive 100-year history; a range of modalities; well-characterized mechanisms of action; a wide array of indications; several counterindications; well-understood, limited side-effects in certain cases; and a scientific literature that now includes more than 400 articles as well as a score of books. No drug resistance to BT has ever been reported.

1. Biophotonic Therapy is the use of light to activate the healing properties of the blood. BT is photomedicine and has a well-characterized clinical profile. A dozen books and some 400 articles in the German, Russian, and English-language medical literature describe Biophotonic Therapy. Other common names for BT are Ultraviolet Blood Irradiation and Photoluminescence Therapy.
2. In BT’s extracorporeal form, ultraviolet and visible light are used to treat a small amount of blood, which is then reinfused.
3. In BT’s intravenous form, a low-intensity laser (generally at 632.8 nm) shines through a waveguide inside a needle into the blood. BT can also be administered sublingually.
   Continue reading 10 Key Points about Biophotonic Therapy

Amid the fanfare regarding initiatives to treat the devastating HIV/AIDS epidemic, a noteworthy finding has been overlooked. After more than two decades of debate, experimentation by patients, and scattered clinical testing of non-drug therapies of HIV, we now know much better which ones actually work.